|
ABOUT COMPANY
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA drugs to treat and protect people from diseases associated with the human papillomavirus (HPV), cancer, and infectious diseases.
|
EARNINGS
Gross Profit (TTM): -86834216
Market Capitalization: 1094007000
Operating Margin (TTM): -34.54
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0.033
Revenue (TTM): 6516200
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0.235
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -1.11
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -108041976
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|